The endocannabinoid system and liver diseases.

Subject: Liver Disease - PUBLISHED VIA Journal of Neuroendocrinology

Author(s):
Caraceni P, Domenicali M, Bernardi M

Department of Internal Medicine, Cardioangiology, Hepatology, Alma Mater Studiorum University of Bologna, Bologna, Italy. paolo.caraceni@unibo.it

 View Source >>

Related Studies:

Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.

Published via PLOS ONE

Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.

Published via European Journal of Pharmacology

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Published via Author Manuscript

Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.

Published via Cell Death & Disease

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.

Published via British Journal of Pharmacology

View all medical studies

Learn More About Cannabis